Published online February 1, 2007
PEDIATRICS Vol. 119 No. 2 February 2007, pp. e320-e324 (doi:10.1542/peds.2006-1400)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daftary, A. S.
Right arrow Articles by Amin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daftary, A. S.
Right arrow Articles by Amin, R.
Related Collections
Right arrow Musculoskeletal System

ARTICLE

Effect of Long-term Steroids on Cough Efficiency and Respiratory Muscle Strength in Patients With Duchenne Muscular Dystrophy

Ameet S. Daftary, MBBSa, Mark Crisanti, PhDb, Maninder Kalra, MDa, Brenda Wong, MDc and Raouf Amin, MDa

a Departments of Pulmonary Medicine
c Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
b Department of Environmental Health, University of Cincinnati, Cincinnati, Ohio

OBJECTIVE. The objective of this study was to determine whether long-term steroid therapy is associated with increased peak cough flow in patients with Duchenne muscular dystrophy and to determine which pulmonary function test variable is most predictive of peak cough flow.

METHODS. In this case-control study, the medical charts of patients who had Duchenne muscular dystrophy and had pulmonary function tests at our institution in the previous 2 years were examined. Steroid-treated patients were on therapy for at least 1 year. The measured pulmonary function tests included forced vital capacity, maximum expiratory pressure, maximum inspiratory pressure, maximum voluntary ventilation, and peak cough flow. Multiple linear regression analysis was used to determine which pulmonary function test measure was most predictive of peak cough flow and assess the influence of steroid treatment and patient age on peak cough flow.

RESULTS. Ten steroid-treated and 25 untreated patients were analyzed. Peak cough flow and maximum expiratory pressure were significantly higher in the steroid-treated patients. Each of the pulmonary function test variables was significantly associated with peak cough flow. The linear model that had the highest adjusted r2 value included only 2 variables: maximum voluntary ventilation and steroid treatment, demonstrating that steroid-treated patients had peak cough flow values that were 27 L/min higher than the untreated patients. The interaction between maximum voluntary ventilation and steroid was not statistically significant, suggesting that the steroid-associated increase in peak cough flow was approximately constant over the observed range of maximum voluntary ventilation values. The effects of maximum voluntary ventilation and treatment group on peak cough flow were not confounded with the patient age.

CONCLUSIONS. Long-term steroid therapy is associated with improved peak cough flow and respiratory muscle strength in patients with Duchenne muscular dystrophy. Maximum voluntary ventilation may be a useful predictor of lung function in Duchenne muscular dystrophy.

Key Words: cough • Duchenne muscular dystrophy • pulmonary • steroids

Abbreviations: DMD—Duchenne muscular dystrophy • FVC—forced vital capacity • PCF—peak cough flow • PFT—pulmonary function test • ATS—American Thoracic Society • MVV—maximum voluntary ventilation • MIP—maximum inspiratory pressure • MEP—maximum expiratory pressure • IRLS—iteratively reweighted least squares

Accepted Aug 25, 2006.




This article has been cited by other articles:


Home page
 ChestHome page
D. J. Birnkrant, H. B. Panitch, J. O. Benditt, L. J. Boitano, E. R. Carter, V. A. Cwik, J. D. Finder, S. T. Iannaccone, L. E. Jacobson, G. L. Kohn, et al.
American College of Chest Physicians Consensus Statement on the Respiratory and Related Management of Patients With Duchenne Muscular Dystrophy Undergoing Anesthesia or Sedation
Chest, December 1, 2007; 132(6): 1977 - 1986.
[Abstract] [Full Text] [PDF]